Linked Life Data

15841714

Source:http://linkedlifedata.com/resource/pubmed/id/15841714

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-4-21
pubmed:abstractText
Azathioprine and 6-mercaptopurine are useful therapies in inflammatory bowel diseases. Despite their efficacy, their use is limited owing to treatment intolerance or toxicity in 10-15% of patients. It has been suggested that both drugs could be interchangeable.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0036-5521
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
52-5
pubmed:meshHeading
pubmed-meshheading:15841714-6-Mercaptopurine, pubmed-meshheading:15841714-Adult, pubmed-meshheading:15841714-Azathioprine, pubmed-meshheading:15841714-Cohort Studies, pubmed-meshheading:15841714-Colitis, Ulcerative, pubmed-meshheading:15841714-Crohn Disease, pubmed-meshheading:15841714-Dose-Response Relationship, Drug, pubmed-meshheading:15841714-Drug Administration Schedule, pubmed-meshheading:15841714-Drug Resistance, pubmed-meshheading:15841714-Female, pubmed-meshheading:15841714-Follow-Up Studies, pubmed-meshheading:15841714-Humans, pubmed-meshheading:15841714-Immunosuppressive Agents, pubmed-meshheading:15841714-Inflammatory Bowel Diseases, pubmed-meshheading:15841714-Male, pubmed-meshheading:15841714-Maximum Tolerated Dose, pubmed-meshheading:15841714-Middle Aged, pubmed-meshheading:15841714-Retrospective Studies, pubmed-meshheading:15841714-Spain, pubmed-meshheading:15841714-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine.
pubmed:affiliation
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. domenech@ns.hugtip.scs.es
pubmed:publicationType
Journal Article